Abstract: Provided are a method for easily and quickly producing a patterned thin film having a high refractive index and a high transparency, and a highly refractive thin film produced by the method. The method comprises a first step: a step of forming, on a substrate, a coating using a sol containing a metal oxide modified with a phosphorus compound represented by the following formula (1): (wherein R1 is a hydrogen atom, an alkyl group, an alkynyl group, an alkenyl group, an aryl group, an aliphatic heterocyclic group, or an aromatic heterocyclic group; R2 is a divalent organic residue; and n is 1 or 2); a second step: a step of curing the coating on the substrate obtained in the first step by light irradiation; and a third step: a step of further adding energy to the cured film obtained in the second step by heating and/or light irradiation.

Abstract: A MOSFET structure and a method for manufacturing the same are disclosed. The method comprises: a. providing a substrate (100); b. forming a silicon germanium channel layer (101), a dummy gate structure (200) and a sacrificial spacer (102); c. removing the silicon germanium channel layer and portions of the substrate which are not covered by the dummy gate structure (200) and located under both sides of the dummy gate structure 200, so as to form vacancies (201); d. selectively epitaxially growing a first semiconductor layer (300) on the semiconductor structure to fill bottom and sidewalls of the vacancies (201); and e. removing the sacrificial spacer (102) and filling a second semiconductor layer (400) in the vacancies which are not filled by the first semiconductor layer (300). In the semiconductor structure of the present disclosure, carrier mobility in the channel can be increased, negative effects induced by the short channel effects can be suppressed, and device performance can be enhanced.

Abstract: Disclosed is a particle manipulation method including steps of moving particles, which exist in a water-based liquid, into a gelled medium that is insoluble or hardly soluble in the water-based liquid in the water-based liquid, and moving the particles, which exist in the gelled medium, to the outside of the gelled medium. Preferably, the gelled medium is a gel that contains chemically crosslinking polymer. Preferably, the gelled medium has a consistency of 340 to 475. In one embodiment, the movement of the particles existing in the water-based liquid to the gelled medium and the movement of the particles existing inside the gelled medium to the water-based liquid are carried out inside a device, the device being loaded with a plurality of water-based liquids and a gelled medium interposed among the water-based liquids.

Abstract: A method for extracting a skeleton form a point cloud includes: obtaining inputted point cloud sampling data; contracting the point cloud using an iterative formula and obtaining skeleton branches, the iterative formula is: argmin X ? ? i ? I ? ? ? j ? J ? ? ? x i - q i ? ? ? ? ( ? x j - q j ? ) + R ? ( X ) , ? wherein R ? ( X ) = ? i ? I ? ? ? i ? ? i ? ? I ? \ ? { i } ? ? ? ? ( ? x i - x i ? ? ) ? i ? ? x i - x i ? ? , ? ? ( r ) = ? - 4 ? ? r 2 h 2 , wherein J represents a point set of the point cloud sampling data, q represents the sampling points in the point set J, I represents a neighborhood point set of the sampling points q, x represents the neighborhood points in the neighborhood point set I, R is a regular term, ? is a weighting coefficient, h is a neighborhood radius of the neighborhood point set I, and ? is a distribution coefficient; and connecti

Abstract: The invention provides peptides and the nucleic acid sequences that encode them. The invention further provides therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of apoptosis associated disorders.

Abstract: A blood purification membrane capable of adsorbing creatinine which is a uremic toxin in the blood and purifying the blood, the blood purification membrane including fibers and particles adhered to the aforementioned fibers, wherein the aforementioned fibers are composed of a polymer insoluble in water, the aforementioned particles contain SiO2 and Al2O3, and pores capable of incorporating at least a portion of the aforementioned uremic toxin are provided in the aforementioned particles.

Abstract: The present invention relates to a pharmaceutical composition for the prevention and treatment of tissue injury caused by irradiation which comprises silkworm hemolymph as an active ingredient. Particularly, when the silkworm hemolymph of the present invention was administered to an animal model with liver damage induced by irradiation, plasma AST and liver MDA were significantly decreased, indicating that the silkworm hemolymph of the invention can be effectively used as a composition for the prevention and treatment of disease caused by the exposure on radiation including tissue injury caused by irradiation, etc.

Abstract: There is provided a method in which a Service Function Forwarding node (SFF) processes traffic. The SFF determines whether a first Service Function Instant (SFI) is in the state of being able to process traffic. The first SFI is locally connected to the SFF, and implements a Service Function (SF) for the processing of traffic. It is determined whether the first SFI is in the state of being able to process traffic. When the first SFI is in the state of being unable to process traffic, the processing of the traffic is requested from a second SFI in which the same SF has been implemented.

Abstract: A technique disclosed herein relates to a manufacturing method for a semiconductor substrate having the bonded interface with high bonding strength without forming an oxide layer at the bonded interface also for the substrate having surface that is hardly planarized. The manufacturing method for the semiconductor substrate may include an amorphous layer formation process in which a first amorphous layer is formed by modifying a surface of a support substrate and a second amorphous layer is formed by modifying a surface of a single-crystalline layer of a semiconductor. The manufacturing method may include a contact process in which the first amorphous layer and the second amorphous layer are contacted with each other. The manufacturing method may include a heat treatment process in which the support substrate and single-crystalline layer are heat-treated with the first amorphous layer and the second amorphous layer being in contact with each other.

Abstract: A synthesis gas and nanocarbon production method has a lower hydrocarbon decomposition step for decomposing lower hydrocarbon to produce hydrogen and nanocarbon, a carbon dioxide reduction step for reacting a part of the nanocarbon produced with carbon dioxide to produce carbon monoxide, and a mixing step for mixing the hydrogen and carbon monoxide produced in a predetermined ratio, thereby nanocarbon and a synthesis gas having a desired gas ratio can be simultaneously produced easily.

Abstract: A method for setting synchronization between terminals performing device-to-device (D2D) communication based on a cellular communication system is disclosed. The method for setting synchronization between terminals includes receiving a message instructing synchronization setting with an opposite terminal from a base station, selecting a first preamble transmitted for a synchronization setting with the opposite terminal based on the message instructing synchronization setting, transmitting the selected first preamble to the opposite terminal, receiving a second preamble from the opposite terminal, and setting the synchronization with the opposite terminal using a reception timing of the second preamble when the second preamble is a preamble designated in the message instructing synchronization setting.

Abstract: The present invention concerns an in vitro method for diagnosing a myeloid tumor or a lymphoid tumor in a subject, which comprises the step of analyzing a biological sample from said subject by (i) detecting the presence of a mutation in the Ten Eleven Translocation protein family member 2 gene (TET2) coding for the polypeptide having the sequence SEQ ID NO:2, and/or (ii) analyzing the expression of the TET2 gene; wherein the detection of such a TET2 mutation, of the absence of expression of TET2 or of the expression of a truncated TET2 is indicative of a subject developing or predisposed to develop a myeloid tumor or a lymphoid tumor.

Abstract: Provided herein are kits and methods suitable for enhancing in vitro translation of a nuclei acid sequence of interest.

Abstract: The invention provides a fusion ferritin protein wherein a ferritin heavy chain polypeptide is fused to a peptide, wherein the peptide is fused to the C-terminal end of the ferritin heavy chain; and the peptide includes at least a portion of a Mms6 protein sequence and at least one heterologous amino acid at its N-terminal end. The invention further provides methods of use of the ferritin fusion protein for Magnetic Resonance Imaging.

Abstract: A system and method for combining k-space data acquired on multiple different receiver channels in a multichannel receiver is provided. One or more convolution kernels are used to combine the k-space data. Each convolution kernel is designed as the combination of one or more channel combination kernels and an alias-suppressing kernel. The channel combination kernels are designed to have a smaller sample spacing than the acquired data, and the alias-suppressing kernel is designed to suppress aliasing artifacts in stopbands defined by the sample spacing of the channel combination kernels.

Abstract: A sanitary disposable urine device is provided. The device includes an inner ring and outer ring each having a top surface and opposing bottom surface. The outer ring is substantially concentric with the inner ring and may be offset. At least one of the top surfaces of the inner and outer rings conforms to a body contour of a user's perineum. The device further includes a hand holder coupled to the bottom surface of the inner ring, the hand holder having an opening configured to match to the inner ring. The device also includes a fluid containing bag having an open end attached to the hand holder such that fluid flows through the inner ring and the opening of the hand holder into the fluid containing bag during usage. The device also includes an inner bag inside the fluid containing bag for containing an absorbent material and an outer sealable bag to secure the device after use.

Abstract: N-Substituted indenoisoquinoline compounds, and pharmaceutical formulations of N-substituted indenoisoquinoline compounds are described. Also described are processes for preparing N-substituted indenoisoquinoline compounds. Also described are methods for treating cancer in mammals using the described N-substituted indenoisoquinoline compounds or pharmaceutical formulations thereof.

Abstract: Disclosed in the present invention is a crosslinked polyethylene composition having improved processability comprises: 100 parts by weight of polyethylene, 0.03-5 parts by weight of crosslinking agent, 0.03-5 parts by weight of crosslinking promoter, and 0.01-1.5 parts by weight of free radical inhibitor, wherein the polyethylene is a copolymer and/or homopolymer containing at least 90 wt. % of vinyl and at least one C3-C8 ?-alkenyl, and has a density in the range of 0.920-0.970 g/cm3, a melt index in the range of 2.5-17.5 g/10 min; the crosslinking agent is a peroxide crosslinking agent; the crosslinking promoter is an organic substance containing maleimido, (meth)acrylate group, and/or allyl, and/or a polymer containing more than 50% of vinyl; the free radical inhibitor is an organic antioxidant, a quinhydrone and/or a substituted quinhydrone.

Abstract: Disclosed is a substrate structure for manufacturing a flexible electronic device, including a supporting layer, a release layer covering the supporting layer with a first area, wherein the release layer is an aromatic polyimide, and a flexible layer covering the supporting layer and the release layer with a second area. The second area is greater than the first area. The adhesion force between the flexible layer and the supporting layer is stronger than the adhesion force between the release layer and the supporting layer.

Abstract: Derivatives of celecoxib that lack cyclooxygenase inhibitory activity but have improved PDE5 inhibitory activity are provided along with pharmaceutical compositions containing them for the treatment or prevention of cancer. Such compounds are expected to have reduced toxicity compared with celecoxib and other cyclooxygenase inhibitors, and greater efficacy compared with conventional PDE5 inhibitors. Derivatives of celecoxib are also suitable for treating chronic inflammatory conditions, erectile dysfunction, pulmonary hypertension, congestive heart failure, and enhancement of cognitive function.